AKAmalia Karahalios

Amalia Karahalios

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amalia Karahalios has a total of 196 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis of comparisons of multiple interventions in infectious diseases research: a scoping review

    by Rukshala K. Gunaratne, Gethmini A. Siriwardena, Robert J. Commons, Megha Rajasekhar, Julie A. Simpson, Amalia Karahalios

    Background: Evidence synthesis in infectious diseases research often involves comparing multiple interventions to assess relative efficacy or safety, usually through pairwise or network meta-analyses. However, the statistical methods used and whether they are applied appropriately in practice are frequently unclear. This scoping review provides an overview of how comparisons of multiple interventions are synthesised in infectious diseases research. Methods: A systematic search was conducted in PubMed, Embase, Web of Science, and the Cochrane Database of Systematic Reviews using search terms related to meta-analyses and infectious diseases. Systematic reviews were included if they quantitatively compared three or more interventions for the prevention or treatment of infectious diseases. Results: Of the 8160 records identified, 420 systematic reviews were eligible after full text screening. A random sample of 200 systematic reviews was selected for data extraction: 100 each from 2015–2019 and 2020–2024, to ensure representation of pre- and post-COVID infectious diseases. Systematic reviews of interventions for COVID-19 (n = 32), HIV/AIDS (n = 22), and hepatitis B (n = 22) were most common. Therapeutic interventions were assessed in 153 (76.5%) systematic reviews and preventive treatments in 47 (23.5%). For statistical comparison of interventions, 34 (17.0%) systematic reviews used only pairwise meta-analyses, 88 (44.0%) used only network meta-analyses, and 78 (39.0%) used both. Of the 166 network meta-analyses, 83 (50.0%) were implemented using a Bayesian framework. Only 41 (24.7%) assessed transitivity, that is, whether it is appropriate to combine evidence from direct and indirect comparisons of interventions, and 112 (67.5%) evaluated consistency, which quantifies the agreement between the effect estimates from direct and indirect comparisons. Conclusion: Network meta-analysis is widely adopted in infectious diseases research. However, the key assumption of transitivity is rarely assessed. Improved adherence to publicly accessible protocols, thorough evaluation of assumptions, and transparent reporting is needed to improve the validity and reproducibility of evidence synthesis in infectious diseases research.

  • Open Access

    NMA-KIT: An interactive knowledge translation tool for network meta-analysis to bridge evidence and practice

    by Tianqi Yu, Tianjing Li, Ian J. Saldanha, Georgia Salanti, Toshi A. Furukawa, Adriani Nikolakopoulou, Theodoros Papakonstantinou, Sally Yaacoub, Haliton Alves Oliveira Junior, Guido Schwarzer, et al.

    Background and Objective: Network meta-analysis (NMA) is increasingly used to compare multiple interventions and inform clinical guidelines, health policy, and decision-making. However, inconsistent reporting and challenges in communicating complex findings can limit the accessibility, transparency, and practical application of NMA results. To address these challenges, we developed the NMA Knowledge Interactive Translation (NMA-KIT) tool, an interactive web-based application integrated within NMAstudio 2.0, to enable a seamless workflow from analysis to communication of results.Methods: The tool was developed to enable a seamless workflow from analysis to communication of results and was demonstrated using an exemplar NMA of systemic treatments for psoriasis.Results: NMA-KIT provides a structured and user-friendly framework for communicating NMA findings. The Detailed Report enables in-depth exploration of treatment effects, underlying data, assumptions, and certainty of evidence, whereas the KIT Summary presents concise, clinically focused results. Additional functionalities include interactive data filtering, customizable visualizations, absolute risk estimation, access to study-level information, and collaborative project sharing.Conclusions: NMA-KIT represents an important step forward for bridging the gap between NMA results and decision-making. By combining interactive visualization, flexible exploration, and integrated project sharing within NMAstudio 2.0, the tool improves transparency, reproducibility, and communication, ultimately supporting more informed and collaborative evidence-based decisions.

  • Mechanisms underlying the effect of adiposity on risk of post-menopausal oestrogen receptor-positive breast cancer: an interventional mediation analysis

    by Frances E M Albers, S Ghazaleh Dashti, Christopher T V Swain, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A Brown, Marc J Gunter, Roger L Milne, Dallas R English, et al.

    Background: Adiposity increases the risk of post-menopausal oestrogen receptor (ER)-positive breast cancer. Inflammation, insulin, and insulin-like growth factors and sex-steroid hormones may explain this effect. We performed interventional mediation analysis to estimate the effects of hypothetical interventions targeting these pathways in females with obesity on reducing their excess risk of post-menopausal ER-positive breast cancer relative to females with normal weight. Methods: The mediation analysis included 1260 post-menopausal females (352 with ER-positive breast cancer) from a case–cohort within the Melbourne Collaborative Cohort Study. A Monte Carlo g-computation approach with non-parametric bootstrapping was used to estimate the risk differences (RDs) and 95% confidence intervals (CIs) for interventional direct and indirect effects of hypothetical interventions that shift the joint distribution of inflammation, insulin, and sex-steroid hormone biomarkers in females with obesity to the levels observed in females with normal weight. Results: The estimated RD for the total effect of obesity relative to normal weight on post-menopausal ER-positive breast cancer was 16.1 (95% CI: 3.3, 30.4) per 1000 females. The RDs for indirect effects through inflammation, insulin, and sex-steroid hormones were 16.4 (95% CI: 4.3, 27.2), −8.4 (95% CI: −23.4, 1.2), and 13.0 (95% CI: 3.3, 23.7) per 1000 females, respectively. The − RD for the direct effect not via any of these three pathways was −5.3 (95% CI: −17.4, 10.6) per 1000 females. Conclusion: Inflammation and sex-steroid hormones, but not insulin, contributed to the detrimental effect of adiposity on the risk of post-menopausal ER-positive breast cancer. Interventions targeting these pathways may reduce the risk for females with obesity.

  • Open Access

    An investigation of the impact of using contrast- and arm-synthesis models for network meta-analysis

    by Amalia Karahalios, Ian R. White, Simon L. Turner, Georgia Salanti, G. Peter Herbison, Areti Angeliki Veroniki, Adriani Nikolakopoulou, Joanne E. McKenzie

    Network meta-analysis allows the synthesis of relative effects from several treatments. Two broad approaches are available to synthesize the data: arm-synthesis and contrast-synthesis, with several models that can be fitted within each. Limited evaluations comparing these approaches are available. We re-analyzed 118 networks of interventions with binary outcomes using three contrast-synthesis models (CSM; one fitted in a frequentist framework and two in a Bayesian framework) and two arm-synthesis models (ASM; both fitted in a Bayesian framework). We compared the estimated log odds ratios, their standard errors, ranking measures and the between-trial heterogeneity using the different models and investigated if differences in the results were modified by network characteristics. In general, we observed good agreement with respect to the odds ratios, their standard errors and the ranking metrics between the two Bayesian CSMs. However, differences were observed when comparing the frequentist CSM and the ASMs to each other and to the Bayesian CSMs. The network characteristics that we investigated, which represented the connectedness of the networks and rareness of events, were associated with the differences observed between models, but no single factor was associated with the differences across all of the metrics. In conclusion, we found that different models used to synthesize evidence in a network meta-analysis (NMA) can yield different estimates of odds ratios and standard errors that can impact the final ranking of the treatment options compared.


  • Open Access

    Table S7 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Estimated residual intra-class correlation coefficients for the total proportion of variation attributable to batch

  • Open Access

    Table S5 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Overall intra-assay and inter-assay coefficients of variation from analysis of quality control samples

  • Open Access

    Table S6 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Estimated intra-batch and inter-batch reliability intra-class correlation coefficients from analysis of quality control samples

  • Open Access

    Figure S2 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Figure S2 presents scatter plots of insulin (Panel A) and c-peptide (Panel B) concentration by time since last meal.

  • Open Access

    Figure S4 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Figure S4 illustrates the assumed relationships between insulin, postmenopausal ER-positive breast cancer, and other measured biomarkers.

  • Open Access

    Figure S5 from Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor–Positive Breast Cancer: A Case–Cohort Analysis

    by Frances E.M. Albers, Christopher T.V. Swain, Makayla W.C. Lou, S. Ghazaleh Dashti, Sabina Rinaldi, Vivian Viallon, Amalia Karahalios, Kristy A. Brown, Marc J. Gunter, Roger L. Milne, et al.

    Figure S5 presents a scatter plot of measured versus reference values of c-peptide.